RDHL — Redhill Biopharma Ltd

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $0.39 Analyst target: $19000.00 Upside: 4899332.70%

About Redhill Biopharma Ltd

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The company is headquartered in Tel Aviv, Israel.

See the full interactive analysis & chart →

Informational only — not investment advice.